Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Omstead

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|February 28, 2019
Polyvalent Nanoobjects for Precision DiagnosticsDavid T Omstead, Jenna Sjoerdsma, Basar Bilgicer
Nanoscale|January 7, 2022
Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticlesFranklin Mejia, Sabrina Khan, David T Omstead, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2020
Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacyBaksun Kim, Jaeho Shin, Junmin Wu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2019
Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitroJared F Stefanick, David T Omstead, Jonathan D Ashley, et al.
Biomaterials|November 28, 2022
Disease-driven engineering of peptide-targeted DM1 loaded liposomal nanoparticles for enhanced efficacy in treating multiple myeloma by exploring DM1 prodrug chemistrySabrina Khan, Franklin Mejia, Jaeho Shin, et al.
Journal of Hematology & Oncology|November 3, 2020
In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myelomaDavid T Omstead, Franklin Mejia, Jenna Sjoerdsma, et al.
Nature Communications|July 1, 2022
Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9Yongyao Fu, Abigail Pajulas, Jocelyn Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annual Review of Analytical Chemistry (Palo Alto, Calif.)|February 28, 2019
Polyvalent Nanoobjects for Precision DiagnosticsDavid T Omstead, Jenna Sjoerdsma, Basar Bilgicer
Nanoscale|January 7, 2022
Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticlesFranklin Mejia, Sabrina Khan, David T Omstead, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 11, 2020
Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacyBaksun Kim, Jaeho Shin, Junmin Wu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2019
Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitroJared F Stefanick, David T Omstead, Jonathan D Ashley, et al.
Biomaterials|November 28, 2022
Disease-driven engineering of peptide-targeted DM1 loaded liposomal nanoparticles for enhanced efficacy in treating multiple myeloma by exploring DM1 prodrug chemistrySabrina Khan, Franklin Mejia, Jaeho Shin, et al.
Journal of Hematology & Oncology|November 3, 2020
In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myelomaDavid T Omstead, Franklin Mejia, Jenna Sjoerdsma, et al.
Nature Communications|July 1, 2022
Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9Yongyao Fu, Abigail Pajulas, Jocelyn Wang, et al.
Pageof 1